Full Press Release Details
Lexicon to Reposition as Clinical Development-Focused Company Following Regulatory Update From FDA.
LXRX
Lexicon to Reposition as Clinical Development-Focused Company Following Regulatory Update From FDA
Key Takeaway: Lexicon to Reposition as Clinical Development-Focused Company Following Regulatory Update From FDA